Showing results (11-20 of 254) with videos related to
Sort By:
Pageof 26
Plos One|November 8, 2012
3-Pyridyl substituted aliphatic cycles as CYP11B2 inhibitors: aromaticity abolishment of the core significantly increased selectivity over CYP1A2Lina Yin, Qingzhong Hu, Rolf W HartmannEuropean Journal of Medicinal Chemistry|February 21, 2016
Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2Marica Mariano, Rolf W Hartmann, Matthias EngelArchiv Der Pharmazie|December 15, 2004
Discovery of inhibitors of MCF-7 tumor cell adhesion to endothelial cells and investigation on their mode of actionThomas Bild, Joachim Jose, Rolf W HartmannJournal of Medicinal Chemistry|January 4, 2013
Tetrahydropyrroloquinolinone type dual inhibitors of aromatase/aldosterone synthase as a novel strategy for breast cancer patients with elevated cardiovascular risksLina Yin, Qingzhong Hu, Rolf W HartmannJournal of Medicinal Chemistry|August 7, 2012
Selective dual inhibitors of CYP19 and CYP11B2: targeting cardiovascular diseases hiding in the shadow of breast cancerQingzhong Hu, Lina Yin, Rolf W HartmannJournal of Medicinal Chemistry|August 21, 2007
Prediction of protein-protein interaction inhibitors by chemoinformatics and machine learning methodsAlexander Neugebauer, Rolf W Hartmann, Christian D KleinMolecular and Cellular Biochemistry|March 29, 2005
5alpha-reductase in human embryonic kidney cell line HEK293: evidence for type II enzyme expression and activityBaerbel U Panter, Joachim Jose, Rolf W HartmannJournal of Mass Spectrometry : JMS|July 30, 2004
Quantitative analysis of 5 alpha-reductase inhibitors in DU145 cells using matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry and high-performance liquid chromatography/tandem mass spectrometryMin-Jung Kang, Sonal Mathur, Rolf W HartmannThe Journal of Steroid Biochemistry and Molecular Biology|June 30, 2005
The adrenocortical tumor cell line NCI-H295R as an in vitro screening system for the evaluation of CYP11B2 (aldosterone synthase) and CYP11B1 (steroid-11beta-hydroxylase) inhibitorsUrsula Müller-Vieira, Marc Angotti, Rolf W HartmannBioorganic & Medicinal Chemistry|January 8, 2011
17β-HSD2 inhibitors for the treatment of osteoporosis: Identification of a promising scaffoldMarie Wetzel, Sandrine Marchais-Oberwinkler, Rolf W HartmannPageof 26